States are leveraging Medicaid waivers as part of their response to the opioid epidemic. Through Section 1115 demonstrations, states are using federal Medicaid funding to provide care to individuals residing in institutions for mental diseases (IMD) and to expand substance use disorder benefits. The Robert Wood Johnson Foundation’s State Health & Value Strategies program, together with technical assistance experts from Manatt Health, hosted a webinar to discuss federal requirements and state considerations associated with securing these waivers. The Robert Wood Johnson Foundation’s State Health & Value Strategies program and Manatt Health were joined by leadership from the New Jersey Department of Human Services, which received approval of its IMD waiver in October 2017 and is now in the implementation phase.
Topics covered include:
- Federal guidance on waivers of the IMD exclusion
- The requirements and conditions states must meet to secure a waiver of the IMD exclusion
- Issues and opportunities arising as states pursue and increasingly implement waivers of the IMD exclusion
- Best practices and lessons learned from New Jersey’s experience implementing its waiver
Click here to view the webinar and download a free copy of the program.
Patricia Boozang, Senior Managing Director, Manatt Health
Mindy Lipson, Senior Manager, Manatt Health
The webinar was held on June 21, 2018.
It was prepared for the Robert Wood Johnson Foundation.
Support for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at firstname.lastname@example.org.
This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.